https://nxtin.health/2026/09/30/life-science-invest-gathers-capital-forces-around-danish-life-science-first-major-investment-shows-clear-value/ 2026-09-30T10:36:19Z NXTin health en Life Science Invest gathers capital forces around Danish life science – first major investment shows clear value 2026-09-30T10:33:57Z Blog https://nxtin.health/2026/09/30/a-look-inside-vilnius-next-innovation-chapter-with-dr-gediminas-pauliukevicius/ 2026-09-30T11:03:27Z NXTin health en A look inside Vilnius’ next innovation chapter with Dr. Gediminas Pauliukevičius 2026-09-30T10:02:06Z Blog https://nxtin.health/2026/09/30/chinese-medical-teams-have-treated-more-than-270000-people-in-malta/ 2026-09-30T09:16:16Z NXTin health en Chinese medical teams have treated more than 270,000 people in Malta 2026-09-30T09:16:13Z Blog https://nxtin.health/2026/09/30/new-ai-tool-assesses-liver-cancer-treatment-success/ 2026-09-30T08:46:43Z NXTin health en New AI tool assesses liver cancer treatment success 2026-09-30T08:46:40Z Blog https://nxtin.health/2026/09/30/incepto-medical-raises-16m-to-accelerate-access-to-trusted-ai-in-medical-imaging/ 2026-09-30T08:23:31Z NXTin health en Incepto Medical raises $16M to accelerate access to trusted AI in medical imaging 2026-09-30T08:22:13Z Blog https://nxtin.health/2026/09/30/niri-and-academic-partners-establish-the-eu-openscreen_lv-network/ 2026-09-30T08:55:17Z NXTin health en NIRI and academic partners establish the EU-OPENSCREEN_LV network 2026-09-30T07:48:20Z Blog https://nxtin.health/2026/09/30/breye-therapeutics-raises-e67-5-million/ 2026-09-30T07:35:50Z NXTin health en Breye Therapeutics raises €67.5M in Series A funding 2026-09-30T06:54:59Z Blog https://nxtin.health/2026/09/29/maltas-first-national-patient-safety-strategy-2026-2035-continues/ 2026-09-30T09:11:13Z NXTin health en Malta's first National Patient Safety strategy 2026–2035 continues 2026-09-29T20:57:00Z Blog https://nxtin.health/2026/09/29/fighting-cancer-stricter-rules-equal-access-to-treatment/ 2026-09-29T11:31:06Z NXTin health en Fighting cancer: stricter rules, equal access to treatment 2026-09-29T11:29:41Z Blog https://nxtin.health/2026/09/29/latvian-biomedical-institutions-and-illumina-agree-to-accelerate-the-development-of-precision-medicine/ 2026-09-30T11:00:57Z NXTin health en Latvian biomedical institutions and Illumina agree to accelerate the development of precision medicine 2026-09-29T10:55:44Z Blog https://nxtin.health/2026/09/29/e1-7-million-in-new-funding-opportunities-for-research-and-innovation/ 2026-09-30T09:46:12Z NXTin health en €1.7 million in new funding opportunities for research and innovation 2026-09-29T09:24:04Z Blog https://nxtin.health/2026/09/29/allan-bohm-on-seerlinq-the-reimbursement-maze-and-what-it-would-take-to-keep-medtech-in-europe/ 2026-09-30T10:16:37Z NXTin health en Allan Böhm on Seerlinq, the reimbursement maze, and what it would take to keep MedTech in Europe 2026-09-29T07:15:04Z Blog https://nxtin.health/2026/09/29/pharma-package-council-adopts-new-rules-for-a-fairer-and-more-competitive-eu-pharmaceutical-sector/ 2026-09-29T05:25:07Z NXTin health en Pharma package: Council adopts new rules for a fairer and more competitive EU pharmaceutical sector 2026-09-29T05:16:23Z Blog https://nxtin.health/2026/09/29/eu-advances-global-health-resilience-initiative-with-new-global-gateway-investments-in-africa-and-latin-america/ 2026-09-29T04:32:42Z NXTin health en EU advances Global Health Resilience initiative with new Global Gateway investments in Africa and Latin America 2026-09-29T04:31:21Z Blog https://nxtin.health/2026/09/29/who-europe-has-launched-a-new-framework-to-help-member-states-assess-their-own-progress-towards-achieving-disability-inclusive-health-systems/ 2026-09-29T04:37:47Z NXTin health en WHO/Europe has launched a new framework to help Member States assess their own progress towards achieving disability-inclusive health systems 2026-09-29T04:14:23Z Blog https://nxtin.health/2026/09/28/camara-looks-to-develop-novel-treatments-for-cardiometabolic-and-renal-diseases/ 2026-09-28T06:22:26Z NXTin health en CaMaRa looks to develop novel treatments for cardiometabolic and renal diseases 2026-09-28T06:22:24Z Blog